These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 3921242

  • 1. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY, Garrett WM, Brodie AM.
    Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
    [Abstract] [Full Text] [Related]

  • 2. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM, Garrett WM, Hendrickson JR, Tsai-Morris CH.
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
    Yamamoto T, Urabe M, Tamura T, Kitawaki J, Honjo H, Okada H.
    Anticancer Res; 1991 Aug; 11(6):1999-2002. PubMed ID: 1776832
    [Abstract] [Full Text] [Related]

  • 4. Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione.
    Wing LY, Hammond JO, Brodie AM.
    Endocrinology; 1988 Jun; 122(6):2418-27. PubMed ID: 3131115
    [Abstract] [Full Text] [Related]

  • 5. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
    Brueggemeier RW, Li PK.
    Cancer Res; 1988 Dec 01; 48(23):6808-10. PubMed ID: 3141048
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y, Karakida T, Sugamata N, Andoh T, Takei H, Takahashi M, Yaguchi S, Matsuno T, Takehara M, Sakato M, Kawashima S, Morishita Y.
    Anticancer Res; 1998 Dec 01; 18(1A):171-6. PubMed ID: 9568073
    [Abstract] [Full Text] [Related]

  • 7. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
    Yue W, Wang J, Savinov A, Brodie A.
    Cancer Res; 1995 Jul 15; 55(14):3073-7. PubMed ID: 7606729
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo studies with aromatase inhibitor 4-hydroxy-androstenedione.
    Brodie AM, Wing LY.
    Steroids; 1987 Jul 15; 50(1-3):89-103. PubMed ID: 3504069
    [Abstract] [Full Text] [Related]

  • 9. The effect of aromatase inhibitor 4-hydroxyandrostenedione on steroid receptors in hormone-dependent tissues of the rat.
    Zhou JL, Brodie A.
    J Steroid Biochem Mol Biol; 1995 Jan 15; 52(1):71-6. PubMed ID: 7857875
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ.
    Cancer Res; 1982 Aug 15; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
    Tanaka M, Yano S, Hasegawa Y, Nakao K.
    Arzneimittelforschung; 1994 Jun 15; 44(6):774-8. PubMed ID: 8053980
    [Abstract] [Full Text] [Related]

  • 18. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N, Koibuchi Y, Iino Y, Morishita Y.
    Int J Oncol; 1999 Feb 15; 14(2):259-63. PubMed ID: 9917500
    [Abstract] [Full Text] [Related]

  • 19. Basic studies on aminoglutethimide.
    Salhanick HA.
    Cancer Res; 1982 Aug 15; 42(8 Suppl):3315s-3321s. PubMed ID: 7083193
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture.
    Yue W, Brodie AM.
    J Steroid Biochem Mol Biol; 1997 Aug 15; 63(4-6):317-28. PubMed ID: 9459198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.